These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

105 related articles for article (PubMed ID: 12678836)

  • 81. Synergistic metabolic benefits of an exenatide analogue and cholecystokinin in diet-induced obese and leptin-deficient rodents.
    Trevaskis JL; Sun C; Athanacio J; D'Souza L; Samant M; Tatarkiewicz K; Griffin PS; Wittmer C; Wang Y; Teng CH; Forood B; Parkes DG; Roth JD
    Diabetes Obes Metab; 2015 Jan; 17(1):61-73. PubMed ID: 25204356
    [TBL] [Abstract][Full Text] [Related]  

  • 82. Discovery of a Positive Allosteric Modulator of Cholecystokinin Action at CCK1R in Normal and Elevated Cholesterol.
    Harikumar KG; Coudrat T; Desai AJ; Dong M; Dengler DG; Furness SGB; Christopoulos A; Wootten D; Sergienko EA; Sexton PM; Miller LJ
    Front Endocrinol (Lausanne); 2021; 12():789957. PubMed ID: 34950108
    [TBL] [Abstract][Full Text] [Related]  

  • 83. Evidence for a functional role of cholecystokinin receptors in the rat thyroid gland.
    Ginda WJ
    Folia Histochem Cytobiol; 2001; 39(4):331-4. PubMed ID: 11766768
    [TBL] [Abstract][Full Text] [Related]  

  • 84. The effect of centrally administered CCK-receptor antagonists on food intake in rats.
    Corp ES; Curcio M; Gibbs J; Smith GP
    Physiol Behav; 1997 Jun; 61(6):823-7. PubMed ID: 9177553
    [TBL] [Abstract][Full Text] [Related]  

  • 85. CCK1R agonists: a promising target for the pharmacological treatment of obesity.
    Szewczyk JR; Laudeman C
    Curr Top Med Chem; 2003; 3(8):837-54. PubMed ID: 12678836
    [TBL] [Abstract][Full Text] [Related]  

  • 86. Role of cholecystokinin and opioid peptides in control of food intake.
    Baile CA; McLaughlin CL; Della-Fera MA
    Physiol Rev; 1986 Jan; 66(1):172-234. PubMed ID: 2868468
    [TBL] [Abstract][Full Text] [Related]  

  • 87. Role of cholecystokinin in the control of food intake.
    Peikin SR
    Gastroenterol Clin North Am; 1989 Dec; 18(4):757-75. PubMed ID: 2693351
    [TBL] [Abstract][Full Text] [Related]  

  • 88. Major biological actions of CCK--a critical evaluation of research findings.
    Fink H; Rex A; Voits M; Voigt JP
    Exp Brain Res; 1998 Nov; 123(1-2):77-83. PubMed ID: 9835394
    [TBL] [Abstract][Full Text] [Related]  

  • 89. Afferent signals regulating food intake.
    Bray GA
    Proc Nutr Soc; 2000 Aug; 59(3):373-84. PubMed ID: 10997653
    [TBL] [Abstract][Full Text] [Related]  

  • 90. Recent advances in the chemistry of cholecystokinin receptor ligands (agonists and antagonists).
    de Tullio P; Delarge J; Pirotte B
    Curr Med Chem; 1999 Jun; 6(6):433-55. PubMed ID: 10213792
    [TBL] [Abstract][Full Text] [Related]  

  • 91. Metabolic Actions of the Type 1 Cholecystokinin Receptor: Its Potential as a Therapeutic Target.
    Miller LJ; Desai AJ
    Trends Endocrinol Metab; 2016 Sep; 27(9):609-619. PubMed ID: 27156041
    [TBL] [Abstract][Full Text] [Related]  

  • 92. Hyperphagia and obesity in OLETF rats lacking CCK-1 receptors.
    Moran TH; Bi S
    Philos Trans R Soc Lond B Biol Sci; 2006 Jul; 361(1471):1211-8. PubMed ID: 16815799
    [TBL] [Abstract][Full Text] [Related]  

  • 93. Unraveling the obesity of OLETF rats.
    Moran TH
    Physiol Behav; 2008 Apr; 94(1):71-8. PubMed ID: 18190934
    [TBL] [Abstract][Full Text] [Related]  

  • 94. Strategies for design of non peptide CCK1R agonist/antagonist ligands.
    García-López MT; González-Muñiz R; Martín-Martínez M; Herranz R
    Curr Top Med Chem; 2007; 7(12):1180-94. PubMed ID: 17584140
    [TBL] [Abstract][Full Text] [Related]  

  • 95. CCK1 antagonists: are they ready for clinical use?
    Peter SA; D'Amato M; Beglinger C
    Dig Dis; 2006; 24(1-2):70-82. PubMed ID: 16699265
    [TBL] [Abstract][Full Text] [Related]  

  • 96. Cholecystokinin (CCK) and related adjunct peptide therapies for the treatment of obesity and type 2 diabetes.
    Pathak V; Flatt PR; Irwin N
    Peptides; 2018 Feb; 100():229-235. PubMed ID: 29412823
    [TBL] [Abstract][Full Text] [Related]  

  • 97. Cholecystokinin: role in thermoregulation and other aspects of energetics.
    Szelényi Z
    Clin Chim Acta; 2010 Mar; 411(5-6):329-35. PubMed ID: 20036221
    [TBL] [Abstract][Full Text] [Related]  

  • 98. The ontogeny of postingestive inhibitory stimuli: examining the role of CCK.
    Weller A
    Dev Psychobiol; 2006 Jul; 48(5):368-79. PubMed ID: 16770766
    [TBL] [Abstract][Full Text] [Related]  

  • 99.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 100.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.